Memory is composed of three stages: acquisition, consolidation, and retriev
al. By impairing acquisition processes, benzodiazepines cause anterograde a
mnesia while leaving intact information learned before the drug was taken.
In some circumstances, retrieval of this information is even improved by be
nzodiazepines. It has been hypothesized that this phenomenon is not a true
facilitation of retrieval processes, but is the result of reduced interfere
nce from items presented after drug administration and is thus a secondary
consequence of drug-induced amnesia. Experiment 1 investigated the effect o
f 0.5, 1, and 2.5 mg of lorazepam on explicit episodic memory in healthy yo
ung volunteers. The l-mg dose was found to significantly improve recall of
items presented before drug administration without causing amnesia for item
s presented after drug administration, thus excluding an interference expla
nation. Experiment 2 investigated the conditions necessary to obtain facili
tated retrieval with 1 mg of lorazepam. The results showed that facilitatio
n was found only when two lists of semantically related material were prese
nted, but that both of the lists could be presented before drug administrat
ion, thus excluding an effect of lorazepam on consolidation. Facilitation c
ould be demonstrated in both direct (free recall) and indirect (backwards r
eading) retrieval tasks and when all of the material was presented after lo
razepam administration. This improved retrieval could therefore be of clini
cal relevance, but any benefits would be reduced at higher doses that at th
e same time impair acquisition of new information. However, because 1 mg of
lorazepam is an effective anxiolytic dose, these results suggest that it i
s possible to combine effective anxiety reduction with some benefits to mem
ory.